Strategic considerations for innovation and commercialization in the US biotechnology sector

Social Sciences

• commercialization 89%
• biotechnology 88%
• firm 66%
• innovation 54%
• large company 29%
• pharmaceutical 19%
• university 19%
• Licensing agreements 16%
• industrial company 16%
• innovation strategy 15%
• entrepreneur 10%
• import 9%
• supplement 9%
• new technology 8%
• marketing 8%
• labor market 8%

Earth & Environmental Sciences

• commercialization 100%
• biotechnology 93%
• firm 83%
• innovation 73%
• drug 17%
• labor market 14%
• entrepreneur 13%
• product development 13%
• marketing 11%
• import 10%
• permitting 10%
• new technology 9%
• attribute 7%
• science 6%
• product 5%